Ampio Pharmaceuticals Statistics
Total Valuation
Ampio Pharmaceuticals has a market cap or net worth of 2,952. The enterprise value is -3.67 million.
| Market Cap | 2,952 |
| Enterprise Value | -3.67M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ampio Pharmaceuticals has 1.14 million shares outstanding. The number of shares has increased by 7.50% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.14M |
| Shares Change (YoY) | +7.50% |
| Shares Change (QoQ) | +2.96% |
| Owned by Insiders (%) | 1.53% |
| Owned by Institutions (%) | 0.00% |
| Float | 1.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.41 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -113.96% and return on invested capital (ROIC) is -72.53%.
| Return on Equity (ROE) | -113.96% |
| Return on Assets (ROA) | -61.57% |
| Return on Capital (ROIC) | -72.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.44M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -99.86% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 45.05 |
| Average Volume (20 Days) | 2,052 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.52M |
| Pretax Income | -8.63M |
| Net Income | -8.63M |
| EBITDA | -9.39M |
| EBIT | -9.52M |
| Earnings Per Share (EPS) | -10.66 |
Balance Sheet
The company has 4.12 million in cash and 451,000 in debt, giving a net cash position of 3.67 million or 3.23 per share.
| Cash & Cash Equivalents | 4.12M |
| Total Debt | 451,000 |
| Net Cash | 3.67M |
| Net Cash Per Share | 3.23 |
| Equity (Book Value) | 3.36M |
| Book Value Per Share | 4.03 |
| Working Capital | 3.36M |
Cash Flow
| Operating Cash Flow | -8.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ampio Pharmaceuticals does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.50% |
| Shareholder Yield | -7.50% |
| Earnings Yield | -410,000.00% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 12, 2023. It was a reverse split with a ratio of 0.05.
| Last Split Date | Sep 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |